Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03292835 |
Date of registration:
|
18/09/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Complex Cutaneous Leishmaniasis Healing Study in Algeria
LeiClean |
Scientific title:
|
Multicentric Non-Interventional Trial Evaluating Painless Hand Hygiene and LeiProtect® Dressing to Treat Complex Cutaneous Leishmaniasis in Algeria - LeiClean |
Date of first enrolment:
|
September 1, 2021 |
Target sample size:
|
100 |
Recruitment status: |
Suspended |
URL:
|
https://clinicaltrials.gov/show/NCT03292835 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Algeria
|
Germany
| | | | | | |
Contacts
|
Name:
|
Zoubir Harrat, Dr. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Pasteur Institute |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Subject has Giemsa and PCR proven L.major cutaneous leishmaniasis
- Subject has complex zoonotic cutaneous leishmaniasis or Sb(V) incompatibility
- Subject gives voluntary consent
Exclusion Criteria:
- Immune deficiencies, skin tumours, allergy to 1,2-propylene glycol (rare)
Age minimum:
N/A
Age maximum:
90 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Cutaneous Leishmaniases
|
Intervention(s)
|
Device: LeiProtect®
|
Primary Outcome(s)
|
Lesion Epithelisation
[Time Frame: 2 months]
|
Secondary Outcome(s)
|
No healing progress with LeiClean
[Time Frame: 2 months]
|
Secondary ID(s)
|
ALG 17/003
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|